共 9 条
- [1] Bourhis LJ, 2015, ACTA CRYSTALLOGR A, V71, P59, DOI [10.1107/S2053273314022207, 10.1107/S205327331402220759]
- [3] FDA, 2002, WAIVER IN VIVO BIOAV
- [4] Polymorphs and hydrates of Etoricoxib, a selective COX-2 inhibitor [J]. CRYSTENGCOMM, 2012, 14 (18): : 5785 - 5794
- [5] The co-crystal structure of etoricoxib-phthalic acid (1/1), C18H15ClN2O2S•C8H6O4 [J]. ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2023, 238 (04): : 641 - 643
- [6] Can we exchange water in a hydrate structure: a case study of etoricoxib [J]. CRYSTENGCOMM, 2016, 18 (16): : 2825 - 2829
- [7] Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930, 10.1107/S2053273314026370]